Orexants, Orexin Receptor Antagonists: Novel Therapeutic Agents for Insomnia Disorder

References (66)

1. 1 American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults [DOI]
2. 2 Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline [DOI]
3. 3 Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis [DOI]
4. 4 Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study [DOI]
5. 5 Neuro-orchestration of sleep and wakefulness [DOI]
6. 6 Discovery and development of orexin receptor antagonists as therapeutics for insomnia [DOI]
7. 7 Automated Detection of Sleep Stages Using Deep Learning Techniques: A Systematic Review of the Last Decade (2010–2020) [DOI]
8. 8 Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders [DOI]
9. 9 The orexin story and orexin receptor antagonists for the treatment of insomnia [DOI]
10. 10 Non-pharmacological Approaches for Management of Insomnia [DOI]
11. 11 Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder [DOI]
12. 12 Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder [DOI]
13. 13 Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders [DOI]
14. 14 An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics [DOI]
15. 15 Lemborexant: First Approval [DOI]
16. 16 Daridorexant: First Approval [DOI]
17. 17 A systematic analysis of ICSD-3 diagnostic criteria and proposal for further structured iteration [DOI]
18. 18 Brain stimulation techniques as novel treatment options for insomnia: A systematic review [DOI]
19. 19 Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations [DOI]
20. 20 The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials [DOI]
21. 21 Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial [DOI]
22. 22 Insomnia Management: A Review and Update [DOI]
23. 23 Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials [DOI]
24. 24 Sleep-Wake Neurochemistry [DOI]
25. 25 A 2023 Update on Managing Insomnia in Primary Care [DOI]
26. 26 Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis [DOI]
27. 27 Dual orexin receptor antagonists for treatment of insomnia: A systematic review and meta-analysis on randomized, double-blind, placebo-controlled trials of suvorexant and lemborexant [DOI]
28. 28 Efficacy of melatonin and ramelteon for the acute and long‐term management of insomnia disorder in adults: A systematic review and meta‐analysis [DOI]
29. 29 Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial [DOI]
30. 30 Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis [DOI]
31. 31 Complementary and alternative treatments for insomnia disorder: a systematic umbrella review [DOI]
32. 32 Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis [DOI]
33. 33 Acute and Chronic Insomnia: What Has Time and/or Hyperarousal Got to Do with It? [DOI]
34. 34 Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study [DOI]
35. 35 Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea [DOI]
36. 36 Updates in insomnia diagnosis and treatment [DOI]
37. 37 Discovery of ORN0829, a potent dual orexin 1/2 receptor antagonist for the treatment of insomnia [DOI]
38. 38 Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study [DOI]
39. 39 Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia [DOI]
40. 40 Assessment of the effect of the dual orexin receptor antagonist daridorexant on various indices of disease severity in patients with mild to moderate obstructive sleep apnea [DOI]
41. 41 Daridorexant for the Treatment of Insomnia [DOI]
42. 42 Efficacy, safety, and tolerability of nivasorexant in adults with binge‐eating disorder: A randomized, Phase II proof of concept trial [DOI]
43. 43 Daridorexant in Insomnia Disorder: A Profile of Its Use [DOI]
44. 44 Pharmacological and non-pharmacological treatments for insomnia [DOI]
45. 45 The neurophysiologic basis of the human sleep–wake cycle and the physiopathology of the circadian clock: a narrative review [DOI]
46. 46 Evaluating lemborexant for the treatment of insomnia [DOI]
47. 47 Experimental Drugs for Panic Disorder: An Updated Systematic Review [DOI]
48. 48 Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia) [DOI]
49. 49 Lemborexant (Dayvigo) for the Treatment of Insomnia.
50. 50 The Discovery of Suvorexant: Lessons Learned That Can Be Applied to Other CNS Drug Development Efforts [DOI]
51. 51 The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 [DOI]
52. 52 Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease [DOI]
53. 53 Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches [DOI]
54. 54 Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities [DOI]
55. 55 Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review [DOI]
56. 56 Orexinergic Receptor Antagonists as a New Therapeutic Target to Overcome Limitations of Current Pharmacological Treatment of Insomnia Disorder [DOI]
57. 57 Emerging and upcoming therapies in insomnia [DOI]
58. 58 Molecular Docking and Dynamics Studies of Withania somnifera Derived Compounds as GABA-A Receptor Modulators for Insomnia [DOI]
59. 59 Improving Sleep Quality, Daytime Sleepiness, and Cognitive Function in Patients with Dementia by Therapeutic Exercise and NESA Neuromodulation: A Multicenter Clinical Trial [DOI]
60. 60 Efficacy and safety of insomnia treatment with lemborexant in older adults: analyses from three clinical trials [DOI]
61. 61 Insomnia: A Current Review.
62. 62 Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo® Tablets [DOI]
63. 63 Effect of nivasorexant ( ACT ‐539313), a selective orexin‐1‐receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects [DOI]
64. 64 Assessment and management of chronic insomnia disorder: an algorithm for primary care physicians [DOI]
65. 65 Pharmacological Treatments of Sleep–Wake Disorders: Update 2023 [DOI]
66. 66 Overview of Adverse Drug Reactions: Classification, Reporting, Prevention, and Role of Pharmacist [DOI]

Cited by 2

2 citations reported by external sources — individual citing-article records aren't available to list yet.

Related research

• Psychological Wellbeing of Healthcare Workers in Different Hospitals of Karachi (Pakistan) During COVID-19 Pandemic — shares topic coverage
• Association of Poor Sleep Quality with Ischemic Heart Disease — shares topic coverage
• Research Findings for Sleep Disorders: A Literature Update — shares topic coverage
• Sleep Patterns Across Different Age Groups: A Survey Study in Ballari City, Karnataka, India — shares topic coverage
• Effect of Aerobic Exercise on Depression and Insomnia in Post Menopausal Women — shares topic coverage